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Abstract
Prion diseases are a group of fatal neurodegenerative disorders caused by prions, which
consist mainly of the abnormally folded isoform of prion protein, PrPSc. A pivotal pathogenic
event in prion disease is progressive accumulation of prions, or PrPSc, in brains through con-
stitutive conformational conversion of the cellular prion protein, PrPC, into PrPSc. However,
the cellular mechanism by which PrPSc is progressively accumulated in prion-infected neu-
rons remains unknown. Here, we show that PrPSc is progressively accumulated in prion-
infected cells through degradation of the VPS10P sorting receptor sortilin. We first show
that sortilin interacts with PrPC and PrPSc and sorts them to lysosomes for degradation.
Consistently, sortilin-knockdown increased PrPSc accumulation in prion-infected cells. In
contrast, overexpression of sortilin reduced PrPSc accumulation in prion-infected cells.
These results indicate that sortilin negatively regulates PrPSc accumulation in prion-infected
cells. The negative role of sortilin in PrPSc accumulation was further confirmed in sortilin-
knockout mice infected with prions. The infected mice had accelerated prion disease with
early accumulation of PrPSc in their brains. Interestingly, sortilin was reduced in prion-
infected cells and mouse brains. Treatment of prion-infected cells with lysosomal inhibitors,
but not proteasomal inhibitors, increased the levels of sortilin. Moreover, sortilin was
reduced following PrPSc becoming detectable in cells after infection with prions. These
results indicate that PrPSc accumulation stimulates sortilin degradation in lysosomes. Taken
together, these results show that PrPSc accumulation of itself could impair the sortilin-medi-
ated sorting of PrPC and PrPSc to lysosomes for degradation by stimulating lysosomal deg-
radation of sortilin, eventually leading to progressive accumulation of PrPSc in prion-infected
cells.
Author summary
Once prions consisting mainly of PrPSc infect hosts, they constitutively propagate in their
brains. Progressive production of PrPSc through the constitutive conformational conver-
sion of PrPC into PrPSc underlies prion propagation. However, the mechanism enabling
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progressive production of PrPSc in prion-infected cells remains unknown. We here found
that the VPS10P sorting receptor sortilin is involved in degradation of PrPC and PrPSc in
infected cells by binding to both molecules and subsequently trafficking them to the lyso-
somal protein degradation pathway. Interestingly, we also found that degradation of sorti-
lin was stimulated in lysosomes in prion-infected cells possibly as a result of the sortilin-
PrPC or -PrPSc complexes being trafficked to lysosomes. Our findings indicate that PrPSc
itself impairs the sortilin-mediated degradation of PrPC and PrPSc by stimulating degrada-
tion of sortilin in lysosomes. This eventually results in progressive production of PrPSc in
prion-infected cells by increasing the opportunity of PrPC to convert into PrPSc and by
accumulating the already produced PrPSc. This mechanism was confirmed in sortilin-KO
mice infected with prions. The mice had exacerbated prion disease with earlier accumula-
tion of PrPSc in their brains.
Introduction
Prion diseases are a group of fatal neurodegenerative disorders, which include Creutzfeldt-
Jakob disease in humans and bovine spongiform encephalopathy and scrapie in animals [1].
They are caused by the infectious agents termed prions, which mainly consist of the abnor-
mally folded, amyloidogenic isoform of prion protein, designated PrPSc. PrPSc is a β-sheet-rich
conformer produced by conformational conversion of the cellular counterpart, PrPC [1]. Inter-
molecular interaction between PrPC and PrPSc is essential for the conversion of PrPC into
PrPSc. We and others have shown that mice devoid of PrPC neither developed the disease nor
accumulated PrPSc even after prions were inoculated into their brains [2–5]. These results indi-
cate that the conversion of PrPC into PrPSc plays a pivotal role in the pathogenesis of prion dis-
ease, and that depletion of PrPC could be therapeutic by preventing the production of PrPSc.
PrPC is normally located at the cell surface as a glycosylphosphatidylinositol (GPI)-
anchored glycoprotein [6]. Some endocytosed PrPC molecules are transported to lysosomes
for degradation while others are recycled to the cell surface through the endocytic recycling
compartments [7]. PrPSc is also trafficked to lysosomes for degradation [7]. However, the cel-
lular transport mechanism of PrPC and PrPSc to lysosomes remains unknown. Whether prion
infection or PrPSc impairs the lysosomal trafficking of PrPC and PrPSc for its progressive prop-
agation is also unknown.
The vacuolar protein sorting-10 protein (VPS10P)-domain receptors, including sortilin,
SorLA, SorCS1, SorCS2 and SorCS3, are multi-ligand type I transmembrane proteins abun-
dantly expressed in the brain and involved in neuronal function and viability [8,9]. They func-
tion as a cargo receptor to deliver a number of cargo proteins to their subcellular destination
through the VPS10P domain in the extracellular luminal N-terminus. Sortilin traffics the amy-
loid precursor protein (APP)-cleaving enzyme BACE1 [10] and the neurotrophic factor recep-
tors Trks [11]. SorLA directs trafficking of APP into the recycling pathway [12]. SorCS1 also
mediates APP transport [13]. Recent lines of evidence indicate that the altered VPS10P recep-
tor-mediated trafficking could be involved in the pathogenesis of neurodegenerative disorders,
including Alzheimer’s disease (AD) [12–15] and frontotemporal lobar degeneration (FTLD)
[16]. However, the role of VPS10P receptors in the trafficking of PrPC or PrPSc and in the path-
ogenesis of prion disease is little known.
In the present study, we show that sortilin has an inhibitory role in PrPSc accumulation by
sorting PrPC and PrPSc to lysosomes for degradation. Interestingly, however, prion infection
stimulates lysosomal degradation of sortilin, indicating that prion infection itself could disturb
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the inhibitory function of sortilin. We also confirm that sortilin-knockout (KO) mice have
accelerated prion disease after infection with RML prions, with early accumulation of PrPSc in
their brains. These results suggest that PrPSc accumulation may be amplified through PrPSc-
induced impairment of the sortilin-mediated lysosomal degradation of PrPC and PrPSc.
Results
Sortilin is a novel PrPC-binding protein regulating the surface levels of
PrPC
To investigate the role of VPS10P cargo receptors in the trafficking of PrPC, we first examined
whether or not VPS10P molecules could interact with PrPC. Co-immunoprecipitation assay in
neuroblastoma N2aC24 cells showed that SAF61 anti-PrP antibody (Ab) precipitated PrPC
with sortilin, but not with other VPS10P molecules (Fig 1A, S1 Fig). PrPC was also co-precipi-
tated with sortilin by anti-sortilin Abs (Fig 1B). GST-pulldown assay using purified recombi-
nant proteins revealed that the VPS10P domain of sortilin fused with GST (GST-VPS10P)
successfully pulled down His-tagged full-length recombinant PrP, but not PrP with a deletion
of 23–88 residues (Fig 1C), suggesting that the residues 23–88 are important for PrPC to inter-
act with sortilin. SAF61 anti-PrP Ab also co-precipitated full-length mycHis-tagged sortilin
expressed in sortilin-KO N2aC24 cells, designated ΔSort#1 cells, but not in PrP-KO N2a
cells, N2aΔPrP#1 cells (S2A and S2B Fig). Both types of KO cells were established using the
CRISPR-Cas genome editing system. This clearly indicates that PrPC expression is required for
sortilin to be co-precipitated by SAF61 anti-PrP Ab, further supporting the interaction of sorti-
lin and PrPC. However, sortilin lacking residues 610–753 was not efficiently co-precipitated
with the Ab, compared to other deletion mutants of sortilin (S2A and S2B Fig), suggesting that
the residues 610–753 of sortilin are involved in interaction with PrPC. Furthermore, co-immu-
noprecipitation assay using mouse brain homogenates also revealed an interaction between
PrPC and sortilin (Fig 1D). Immunofluorescence staining of non-permeabilized N2aC24 cells
showed co-localization of sortilin and PrPC on the cell surface (Fig 1E and 1F; S3 Fig). Intracel-
lular co-localization of sortilin and PrPC was also observed in permeabilized cells (Fig 1E and
1F; S3 Fig).
To further investigate PrPC interaction with sortilin on the cell surface, we labeled PrPC on
the cell surface of N2aC24 cells with SAF61 anti-PrP Ab, lysed the cells, and incubated the
lysate with protein-G-conjugated Dynabeads (S4A Fig). The Ab-labeled PrPC complexes were
collected using magnet (S4A Fig). N2aΔPrP#1 cells were used as negative control (S4A Fig).
Sortilin was co-collected with PrPC from N2aC24 cells, but not from N2aΔPrP#1 cells (S4B
Fig). Sortilin was similarly expressed in N2aC24 and N2aΔPrP#1 cells (S4C Fig). These results
further support PrPC interacting with sortilin on the cell surface.
We then knocked down sortilin in N2aC24 cells using two sortilin-specific siRNAs, termed
siRNA#1 and #2. Immunostaining of sortilin-knockdown (Sort-KD) cells showed an increase
in PrPC expression on the cell surface (Fig 2A). Biotin labeling of surface proteins confirmed
the increased surface levels of PrPC in Sort-KD cells (Fig 2B and 2C). Total PrPC levels were
also increased in Sort-KD cells (Fig 2B and 2C). However, intracellular PrPC was not increased
in Sort-KD cells (Fig 2D), indicating that the surface PrPC is specifically increased in Sort-KD
cells. PrP mRNA levels were not increased in Sort-KD cells (Fig 2E), suggesting that the
increased surface expression of PrPC might be attributable to the impaired degradation of
PrPC in Sort-KD cells. PrPC levels were also significantly increased in the brains of sortilin-KO
(Sort1-/-) mice compared to those in wild-type (WT) mice (S5A and S5B Fig).
PrPC undergoes an endopeptidic cleavage by the ADAM family of metalloproteases, with
the C-terminal fragment, designated the C1 fragment, being produced [17,18]. Sort-KD cells
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Fig 1. PrPC directly interacts with sortilin on the cell surface and inside cells. (A, B) Co-immunoprecipitation assay in
N2aC24 cells with SAF61 anti-PrP Ab (A) or rabbit polyclonal anti-sortilin Abs (B). Arrows and arrowheads indicate a non-
specific signal of the degraded fragment of protein G or the light chain of antibodies used in co-immunoprecipitation.
Percentages indicate the proportion of the sample loaded. (C) GST-pulldown assay using GST-tagged VPS10P domain of
sortilin and His-tagged full-length recombinant PrP or His-tagged recombinant PrP lacking residues 23–88. Percentages
indicate the proportion of the sample loaded. (D) Co-immunoprecipitation assay in mouse brain homogenate with SAF61 anti-
PrP Ab. Percentages indicate the proportion of the sample loaded. Arrowheads indicate a non-specific signal of the degraded
fragment of protein G. (E) Double immunofluorescence staining of PrPC (green) and sortilin (red) in permeabilized or non-
permeabilized N2aC24 cells, with SAF83 anti-PrP Ab and goat polyclonal anti-sortilin Abs. Arrowheads indicate co-localized
signals of PrPC and sortilin. Bar, 5 μm. (F) Person’s correlation coefficient for cell surface and intracellular co-localization of
PrPC and sortilin.
https://doi.org/10.1371/journal.ppat.1006470.g001
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Fig 2. Knockdown of sortilin increases PrPC on the cell surface. (A) Immunofluorescence staining of PrPC with SAF83
anti-PrP Ab in permeabilized N2aC24 cells 6 days after transfection with control or sortilin-specific siRNAs. Bar, 10 μm. (B)
Biotin labeling of surface proteins in N2aC24 cells 6 days after transfection with control or sortilin-specific siRNAs. The
biotinylated surface proteins were purified using NeutrAvidin beads. The surface (biotinylated) PrPC and total (biotinylated
+unbiotinylated) PrPC were analyzed by Western blotting with 6D11 anti-PrP Ab. (C) Quantification of PrPC in (B) after
normalization against β-actin. Each signal intensity in Sort-KD cells was evaluated against that in control cells. Data are
means ± standard deviation (SD) of 3 independent experiments. ** p < 0.01. (D) Quantification of intracellular PrPC in (A). Data
are means ± SD of 9 cells for each cell type. (E) RT-PCR for PrP in N2aC24 cells transfected with control siRNA or sortilin-
specific siRNAs. GAPDH, glyceraldehyde-3-phosphate dehydrogenase.
https://doi.org/10.1371/journal.ppat.1006470.g002
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produced the C1 fragment more abundantly than N2aC24 cells (S6A Fig). This is probably
because PrPC was increased on the cell surface in Sort-KD cells. We also investigated PrPC lev-
els in exosomes of N2aC24 and sortilin-KO ΔSort#1 and ΔSort#2 cells. ΔSort#1 and ΔSort#2
cells also showed an increase in total PrPC levels (S6B Fig). PrPC was significantly higher in
exosomes from ΔSort#1 and #2 cells than in those from N2aC24 cells (S6B and S6C Fig). Exo-
somes were verified by the presence of exosome-specific molecules TSG101 and flotillin and
the absence of GM130 and Bcl-2, both of which are not normally included in exosomes (S6B
Fig) [19,20].
Sortilin sorts surface PrPC to late endosomes/lysosomes
To address whether or not sortilin could sort surface PrPC to lysosomes for degradation, we
first investigated the role of sortilin in internalization of surface PrPC using an Ab-labeling
technique. Surface PrPC was labeled with SAF61 anti-PrP Ab at 4˚C in which internalization
of membrane proteins is inhibited, and then allowed to be internalized for 2 h at 37˚C. The
labeled PrPC was then detected using Alexa Fluoro 488-conjugated anti-mouse IgG Abs. The
internalization of the labeled PrPC was slightly but significantly inhibited in Sort-KD cells,
compared to that in control N2aC24 cells (Fig 3A and 3B), suggesting that sortilin could be
involved in internalization of some portions of PrPC. To further confirm the involvement of
sortilin in internalization of PrPC, we biotinylated the surface proteins of N2aC24 cells and
sortilin-KO (ΔSort) cells #1 with sulfo-NHS-SS-biotin, whose biotin motif can be removed by
reducing agents. We then allowed the biotinylated proteins to be internalized for 2 h, and
treated the cells with the membrane-impermeable reducing agent glutathione to remove the
biotins only from surface proteins but not from those internalized. The treated cells were
lysed, and then biotin-labeled, internalized proteins were purified using avidin-beads, and
investigated for internalized PrPC by Western blotting with 6D11 anti-PrP Ab. Strong signals
corresponding to the internalized PrPC were detected in N2aC24 cells (Fig 3C and 3D). How-
ever, the signals were significantly reduced in ΔSort#1 cells (Fig 3C and 3D). These results
reinforce the role of sortilin in internalization of PrPC.
To track the SAF61 anti-PrP Ab-labeled, internalized PrPC in N2aC24 and Sort-KD cells,
we immunofluorescently stained both types of cells for internalized PrPC with the late endo-
some marker Rab9 or the recycling endosome marker Rab11. The labeled PrPC was normally
internalized to both late endosomes and recycling endosomes, as observed in N2aC24 cells
(Fig 3E and 3F; S7A–S7D Fig). However, in Sort-KD cells, localization of PrPC was markedly
shifted from the late endosomes (Fig 3E; S7A and S7B Fig) to the recycling endosomes (Fig 3F;
S7C and S7D Fig). These results indicate that internalization of PrPC to the recycling endo-
somes could be independent of sortilin. Furthermore, sortilin could function to sort surface
PrPC to the late endosome/lysosome degradation pathway, thereby regulating levels of surface
PrPC. Consistent with the results from Sort-KD cells, sortilin-KO ΔSort#1 cells showed higher
expression of PrPC than control N2aC24 cells (Fig 3G and 3H). Inhibition of lysosomal
enzymes by NH4Cl increased PrP
C markedly in N2aC24 cells, but only slightly in ΔSort#1 cells
(Fig 3G and 3H). PrPC was detected in the LAMP1-positive lysosomes in both cell types after
NH4Cl treatment (Fig 3I and 3J). However, its lysosomal localization was much less in ΔSort#1
cells than in N2aC24 cells (Fig 3I and 3J). These results confirm that transport of PrPC to lyso-
somes is disturbed in sortilin-deficient cells, therefore reducing the localization of PrPC in
lysosomes and resulting in an increase in PrPC levels in sortilin-deficient cells.
We also investigated localization of PrPC in early endosomes in N2aC24 and Sort-KD cells.
PrPC was labeled with SAF61 Ab and spontaneously internalized for 1 h instead of 2 h, which
was utilized for detection of internalized PrPC in late endosomes or recycling endosomes,
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Fig 3. Sortilin is an endocytic receptor for PrPC to late endosomes. (A) Representative images of the
SAF61 Ab-labeled PrPC allowed to be endocyosed in N2aC24 cells after transfection with control or sortilin-
specific siRNAs. The labeled PrPC was visualized with Alexa Fluoro 488 goat anti-mouse IgG Abs. Arrowheads
indicate signals of the internalized PrPC. Bar, 10 μm. (B) Quantification of the labeled PrPC internalized against
the total labeled PrPC in (A). Data are means ± SD of 10–13 cells. *** p < 0.001. (C) Internalization assay of
biotinylated cell surface PrPC in N2aC24 cells and sortilin-KO N2aC24 cells, or ΔSort#1 cells. The cell surface
proteins were biotinylated and allowed to internalize for 2 h. Biotins were removed only from cell surface proteins
but not from those already internalized using reducing glutathione. The biotin-labeled internalized proteins were
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because PrPC may be only transiently located in early endosomes before being trafficked to
late endosomes/lysosomes or recycling endosomes. Indeed, only a very small fraction of PrPC
was detected in the EAA1-positive early endosomes in N2aC24 cells (S7E and S7F Fig). PrPC
was slightly, but not significantly, less localized in early endosomes in Sort-KD cells than in
N2aC24 cells (S7E and S7F Fig). This might be consistent with the sortilin-independent traf-
ficking of PrPC being active through early endosomes.
We also investigated the internalization of PrP with a deletion of 23–88 residues, PrPΔ23–
88, to lysosomes by establishing PrP-KO N2aΔPrP cells permanently expressing wild-type
(WT) mouse PrPC (WT#1 and #2) or PrPΔ23–88 (Δ23–88#1 and #2). Western blotting showed
that PrPΔ23–88 was expressed at higher levels than WT PrPC without NH4Cl treatment (S8A
and S8B Fig), suggesting that PrPΔ23–88 might be less degraded than WT PrPC. NH4Cl treat-
ment only slightly increased PrPΔ23–88 in Δ23–88#1 and #2 cells, but markedly increased WT
PrPC in WT#1 and #2 cells (S8A and S8B Fig). NH4Cl treatment also only slightly increased
PrPΔ23–88 in the LAMP1-positive lysosomes in Δ23–88#1 and #2 cells, but markedly
increased WT PrPC in the lysosomes in WT#1 and #2 cells (S8C and S8D Fig). These results
suggest that residues 23–88 could be involved in trafficking of PrPC to lysosomes for degrada-
tion. Sortilin expression was unaffected in Δ23–88#1 and #2 cells (S8E and S8F Fig). No inter-
action between sortilin and PrPΔ23–88 was detected (S8G Fig). It is thus conceivable that the
interaction with sortilin could be important for PrPC transportation to lysosomes for degrada-
tion. However, the increased localization of PrPΔ23–88 in lysosomes after NH4Cl treatment in
Δ23–88#1 and #2 cells suggests that other molecules are also involved in trafficking of PrPC to
lysosomes.
PrPC shifts to raft domains in sortilin-KO cells
To gain insight into the mechanism of sortilin-mediated sorting of PrPC to lysosomes, we
investigated membrane microdomain localization of PrPC in N2aC24 and sortilin-KO
N2aC24 cells, ΔSort#1 and ΔSort#2 cells, by detergent-based biochemical membrane fraction-
ation. PrPC was detected in both detergent-resistant membrane (DRM) and detergent-soluble
membrane fractions, that is raft and non-raft fractions, in N2aC24 cells, with higher amounts
of PrPC in raft fractions (63.0%) than in non-raft fractions (37.0%) (Fig 4A and 4B). However,
in ΔSort#1 and #2 cells, PrPC in non-raft fractions was reduced to 11.9 and 14.9%, respectively
(Fig 4A and 4B). Instead, PrPC was increased in raft fractions (Fig 4A and 4B). These results
suggest that sortilin could shift the localization of PrPC to non-raft domains from raft domains.
Raft-resident protein flotillin-2 was observed in raft fractions in N2aC24 and ΔSort cells (Fig
4C), ruling out the possibility that lack of sortilin could affect the membrane microdomain
integrity leading to the shift in the location of surface PrPC in ΔSort cells. Sortilin was predom-
inantly detected in non-raft fractions in N2aC24 and ΔSort cells (Fig 4D), indicating that
purified using avidin-beads and subjected to Western blotting with 6D11 anti-PrP Ab. (D) Signal intensities in
each lane in Sort-KD cells were evaluated against that of total PrP signals in N2aC24 cells. Data are means ± SD
of 3 independent experiments. * p < 0.05, ** p < 0.01, *** p < 0.001. (E, F) Double immunofluorescence staining
of the internalized, SAF61-labeled PrPC (green) and the late endosome marker Rab9 (red) or the recycling
endosome marker Rab11 (red) in permeabilized N2aC24 cells transfected with control or sortilin-specific
siRNAs. Bar, 10 μm. (G) Western blotting for PrPC and sortilin in N2aC24 and sortilin-KO (ΔSort#1) cells after 12
h-treatment with or without 20 mM NH4Cl. (H) Quantification of PrPC in (G) after normalization against β-actin.
Signal intensity in NH4Cl-treated cells was evaluated against that in NH4Cl-untreated N2aC24 cells. Data are
means ± SD of 3 independent experiments. *** p < 0.001. (I) Double immunofluorescence staining of PrPC and
the lysosome marker LAMP1 in N2aC24 and sortilin-KO (ΔSort#1) cells after 12 h-treatment with 20 mM NH4Cl.
Bar, 10 μm. (J) Pearson’s correlation coefficient for co-localization of PrPC and LAMP1 in N2aC24 cells treated
(n = 106) and untreated (n = 151) with NH4Cl and in ΔSort#1 cells treated (n = 140) and untreated (n = 166) with
NH4Cl. Data are means ± SD. *** p < 0.001.
https://doi.org/10.1371/journal.ppat.1006470.g003
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sortilin is a non-raft protein. We also performed the membrane fractionation assay for PrPC-
expressing WT#1 and #2 cells and PrPΔ23-88-expressing Δ23–88#1 and #2 cells. PrPC was
detected in raft and non-raft fractions in WT cells (S9A and S9B Fig). However, PrPΔ23–88
increased its localization at raft fractions (S9A and S9B Fig). These results indicate that resi-
dues 23–88 are important for PrPC to be retained at non-raft domains. We then investigated
membrane microdomain localization of PrPC in the brains of Sort1-/- and WT mice. Localiza-
tion of PrPC at raft and non-raft fractions was observed in WT brains (S9C and S9D Fig).
However, PrPC was increased in raft fractions in Sort1-/- brains (S9C and S9D Fig). Taken
together, these results suggest that sortilin might function to retain surface PrPC in non-raft
domains and sort the non-raft PrPC to the late endosome/lysosome degradation pathway
through interaction with residues 23–88 of PrPC.
Fig 4. Membrane microdomain distribution of PrPC is changed in sortilin-KO cells. (A) Discontinuous sucrose gradient
centrifugation of N2aC24 and sortilin-KO (ΔSort#1 and #2) cells was carried out to see membrane microdomain distribution of PrPC. (B)
Quantification of PrPC in each fraction against the total PrPC in (A). The signal density in each lane was evaluated against the total signal
density of all lanes. Data are means ± SD of 3 independent experiments. (C) Discontinuous sucrose gradient centrifugation of N2aC24
and sortilin-KO (ΔSort#1 and #2) cells was carried out to see membrane microdomain distribution of flotillin-2. (D) Discontinuous sucrose
gradient centrifugation of uninfected N2aC24 for sortilin.
https://doi.org/10.1371/journal.ppat.1006470.g004
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We also investigated membrane microdomain location of PrP molecules in prion-infected
N2aC24L1-3 cells. In contrast to PrPC detected in raft and non-raft domains in uninfected
N2aC24 cells (Fig 4A and 4B), total PrP molecules and PK-resistant PrPSc were predominantly
detected in raft fractions in prion-infected N2aC24L1-3 cells (S10A and S10B Fig). These
results suggest that prion infection accumulates PrPSc and PrPC in raft domains.
Sortilin interacts with PrPSc and facilitates its degradation
We also assessed the role of sortilin in the degradation of PrPSc. Protein interaction assay using
protein-G-conjugated magnetic beads in prion-infected N2aC24L1-3 cells showed that PrPSc
and sortilin were co-collected by anti-sortilin Abs (Fig 5A), suggesting that sortilin interacts
with PrPSc. siRNA-mediated knockdown of sortilin increased PrPSc in N2aC24L1-3 cells (Fig
5B and 5C). In contrast, overexpression of sortilin reduced PrPSc in N2aC24L1-3 cells (Fig 5D
and 5E). These results indicate that sortilin could also be involved in PrPSc degradation.
We then evaluated the degradation kinetics of PrPSc in prion-infected cells with or without
sortilin. For this study, it is important to prevent the de novo production of PrPSc from PrPC.
PrP siRNA#1 and #2 reduced PrPC in N2aC24 and ΔSort#1 cells from 24 h after transfection,
to less than 10% of that in control siRNA-transfected N2aC24 and ΔSort#1 cells (Fig 6A).
These results indicate that the de novo production of PrPSc from PrPC could be negligible from
24 h after transfection with PrP siRNAs in these cells even after infection with prions. We thus
investigated PrPSc in RML-infected N2aC24 (N2aC24/RML) and ΔSort#1 (ΔSort/RML) cells at
36, 48 and 60 h after transfection with PrP siRNAs. Control siRNA did not affect PrPSc levels
in these cells (S11A and S11B Fig). However, PrPSc was decreased after transfection with PrP
siRNAs (Fig 6B). In N2aC24/RML cells 60 h after transfection with PrP siRNAs, PrPSc was
reduced to less than 20% of that in control siRNA-transfected N2aC24/RML cells (siRNA#1,
16.5%; siRNA#2, 17.1%) (Fig 6B and 6C). However, significantly higher levels of PrPSc were
still observed in ΔSort/RML cells 60 h after transfection with PrP siRNAs (siRNA#1, 45.2%;
siRNA#2, 38.5%) (Fig 6B and 6C). Similar results were obtained in 22L prion-infected N2aC24
and ΔSort#1 cells (S11C and S11D Fig). These results indicate that sortilin is also involved in
the degradation of PrPSc.
Prion infection cell-autonomously reduces sortilin after PrPSc production
We then asked if prion infection could affect sortilin. Interestingly, sortilin was reduced in
N2aC24L1-3 cells to 52% of that in N2aC24 cells (Fig 7A and 7B). However, other VPS10P
molecules were not reduced (S12A and S12B Fig). The reduced levels of sortilin were recov-
ered in cured N2aC24L1-3 cells, which were cured from prion infection after treatment with
SAF32 anti-PrP Ab, to that in N2aC24 cells (Fig 7A and 7B). Sortilin mRNA was similarly
expressed between N2aC24 and N2aC24L1-3 cells (S12C Fig). ScN2a cells, N2a cells persis-
tently infected with RML prions, also expressed sortilin less than N2a cells (S12D and S12E
Fig). Moreover, sortilin was reduced in the brains of terminally ill mice infected with RML and
22L prions to 46.3 and 45.6%, respectively, compared to uninfected mouse brains (Fig 7C and
7D). These results indicate that prion infection could reduce sortilin.
We then treated uninfected N2aC24 and infected N2aC24L1-3 cells with inhibitors to lyso-
somes (NH4Cl and concanamycin A) or proteasomes (MG132). Treatment with NH4Cl or
concanamycin A increased sortilin in uninfected cells (S13A–S13D Fig). However, sortilin
was much more increased in infected cells after treatment with NH4Cl and concanamycin A
(S13A–S13D Fig). In contrast, MG132 did not affect sortilin levels (S13A and S13B Fig). These
results suggest that sortilin could be degraded in lysosomes, and that the lysosomal degrada-
tion of sortilin could be stimulated in prion-infected cells.
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Fig 5. Sortilin regulates PrPSc levels in prion-infected cells. (A) Protein interaction assay using protein-G-
conjugated magnetic beads in 22L-infected N2aC24L1-3 cells with rabbit polyclonal anti-sortilin Abs. The
immunocomplexes were digested with proteinase K (PK) (100 μg/mL) at 37˚C for 1 h and subjected to
Western blotting for PrPSc. Sortilin was also detected by Western blotting. (B) Western blotting for PrPSc and
sortilin in N2aC24L1-3 cells 4 days after transfection with control and sortilin-specific siRNAs. (C)
Quantification of PrPSc in (B) after normalization against β-actin. Each signal intensity in Sort-KD cells was
evaluated against that in control cells. * p < 0.05. (D) Western blotting for PrPSc and sortilin in N2aC24L1-3
cells 3 days after transfection with control pcDNA or pcDNA-Sortilin. (E) Quantification of PrPSc in (D) after
normalization against β-actin. Signal intensity in sortilin-overexpressing cells (Sortilin) was evaluated against
that in control cells (pcDNA). Data are means ± SD of 3 independent experiments. ** p < 0.01.
https://doi.org/10.1371/journal.ppat.1006470.g005
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Fig 6. PrPSc degradation is delayed in sortilin-knockdown cells infected with RML prions. (A) Western
blotting for PrPC in N2aC24 and ΔSort#1 cells at 12, 24, 48 and 72 h after transfection with control and PrP-
specific siRNAs. (B) Western blotting for PrPSc in RML-infected N2aC24 (N2aC24/RML) and RML-infected
ΔSort#1 (ΔSort/RML) cells 36, 48 and 72 h after transfection with control and PrP-specific siRNAs. (C)
Quantification of PrPSc in (B) after normalization against β-actin. Signal intensities in each lane in PrP-
knockdown cells were evaluated against that in control siRNA-transfected cells in each blot. Data are
means ± SD of 3 independent experiments. n.s., not significant; * p < 0.05, ** p < 0.01, *** p < 0.001.
https://doi.org/10.1371/journal.ppat.1006470.g006
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Fig 7. Prion infection decreases sortilin in a cell-autonomous way. (A) Western blotting for sortilin in
N2aC24, N2aC24L1-3, and cured N2aC24L1-3 cells. PrPC and PrPSc were also detected by Western blotting.
(B) Quantification of sortilin in (A) after normalization against β-actin. The signal intensities in infected and cured
cells were evaluated against those in uninfected cells. Data are means ± SD of 3 independent experiments. n.s.,
not significant; *** p < 0.001. (C) Western blotting for sortilin in the brains of mice infected with or without RML
and 22L prions. PrPC and PrPSc were also detected by Western blotting. (D) Quantification of sortilin in (C) after
normalization against β-actin. The signal intensity in RML or 22L-infected brains was evaluated against that in
uninfected brains. Data are means ± SD of 3 independent brains. *** p < 0.001. (E) Western blotting for sortilin
in N2aC24 cells 3 and 6 days after freshly infected with RML prions. PrPC and PrPSc were also detected by
Western blotting. (F) Quantification of sortilin in (E) after normalization against β-actin. Signal intensity in infected
Prions amplify via sortilin degradation
PLOS Pathogens | https://doi.org/10.1371/journal.ppat.1006470 June 30, 2017 13 / 30
We also monitored the levels of sortilin in N2aC24 cells freshly infected with RML prions.
There was no significant decrease in sortilin by 3 days post-infection (dpi) while PrPSc was
obviously detectable (Fig 7E and 7F). Sortilin was decreased at 6 dpi (Fig 7E and 7F). These
results suggest that prion infection reduces sortilin, and that the sortilin reduction is preceded
by PrPSc production. We also performed double immunofluorescence staining for sortilin
and PrPSc in freshly infected N2aC24 cells at 9 dpi. PrPSc was specifically stained using the
mAb132, which was demonstrated to specifically visualize PrPSc under partially denatured
conditions [21]. Since the subcellular positions of sortilin and PrPSc might differ vertically in
infected cells, 6 horizontally serial images at 1 μm interval were used to detect sortilin and
PrPSc. In cells displaying green fluorescence for PrPSc, little or no sortilin (red fluorescence)
was detected in any slices (Fig 7G). In contrast, bright red fluorescence for sortilin was
observed only in the cells negative for PrPSc (Fig 7G). These results indicate that prion infec-
tion could reduce sortilin in a cell-autonomous fashion after PrPSc accumulation.
Sortilin is known to interact with and transport Trk receptors to the cell surface, thereby
enhancing nerve growth factor (NGF) signaling leading to activation of MAP kinases [11]. To
investigate whether or not prion infection could affect the function of sortilin, we stimulated
uninfected N2aC24 and prion-infected N2aC24L1-3 cells with NGF. Phosphorylated ERK1/2
was increased in N2aC24 and N2aC24L1-3 cells after stimulation (S14A–S14C Fig). However,
the levels of phosphorylated ERK1/2 were significantly lower in N2aC24L1-3 cells than in
N2aC24 cells (S14A–S14C Fig). These results indicate that NGF signaling is impaired in
N2aC24L1-3 cells, suggesting that sortilin might be functionally disturbed in prion-infected
cells.
Prion disease is aggravated in sortilin-KO mice after infection with prions
We then evaluated the effects of sortilin deficiency on the pathogenesis of prion disease using
sortilin-KO (Sort1-/-) mice. Sort1-/- mice were viable and fertile and showed no gross abnor-
malities [11,22]. Sort1+/+ (n = 19) and Sort1-/- female mice (n = 24) were intracerebrally inocu-
lated with RML prions. Incubation and survival times were significantly shortened in Sort1-/-
mice (Fig 8A, S1 Table). Sort1-/- and Sort1+/+ mice developed symptoms at 150.9 ± 7.8 and
171.9 ± 6.0 dpi, respectively (Fig 8A, S1 Table). Western blotting also showed earlier accumula-
tion of PrPSc in the brains of infected Sort1-/- mice. PrPSc was scarcely detectable in the brains
of Sort1+/+ mice at 45 dpi (Fig 8B and 8C). However, it was obvious in Sort-/- mice at 45 dpi
(Fig 8B and 8C). PrPSc levels were still significantly higher in Sort1-/- mice than in Sort1+/+
mice at 60 and 90 dpi (Fig 8B and 8C). However, no difference in the levels of PrPSc was
observed between Sort1+/+ and Sort1-/- mice at terminal stage (Fig 8B and 8C). Immunohisto-
chemical analysis of the brains of infected Sort1+/+ and Sort1-/- mice for PrPSc showed consis-
tent results. PrPSc was detectable in a much larger area of the brains of Sort1-/- mice, compared
to that in Sort1+/+ mice, at 60 dpi (Fig 8D). However, PrPSc became indistinguishably accumu-
lated throughout the brains of Sort1-/- and Sort1+/+ mice at terminal stage (Fig 8D). Similar
results were also obtained with Sort1-/- and Sort1+/+ male mice inoculated with RML prions
(S15A–S15D Fig, S2 Table). These results show that sortilin deficiency accelerates prion dis-
ease by causing early accumulation of PrPSc in the brains of mice after infection with prions,
reinforcing the inhibitory role of sortilin in the pathogenesis of prion disease.
cells was evaluated against that in uninfected cells. Data are means ± SD of 3 independent experiments. n.s., not
significant; * p < 0.05. (G) Double immunofluorescent staining of sortilin (red) and PrPSc (green) in N2aC24 cells
9 days after being freshly infected with RML prions. DAPI was used for nuclear stain (blue). Six serial vertical
images of the cells with 1 μm intervals are shown. Arrows indicate PrPSc-positive cells. Bar, 10 μm.
https://doi.org/10.1371/journal.ppat.1006470.g007
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Fig 8. Sortilin-KO mice have accelerated prion disease with earlier accumulation of PrPSc in their brains. (A)
Kaplan-Meier survival curves for Sort1-/- and Sort1+/+ female mice inoculated with RML prions. Data was statistically
analyzed using the log-lank test (Sort-/-, n = 24; Sort+/+, n = 19). *** p < 0.001. (B) Western blotting for PrPSc in the
brains of Sort1-/- and Sort1+/+ female mice 45, 60, 90 dpi and at terminal stage. Sortilin was also detected by Western
blotting. (C) Quantification of PrPSc in (B) after normalization against β-actin. Signal intensity in Sort1-/- mice was
evaluated against that in Sort1+/+ mice. Data are means ± SD of 4–5 independent brains. n.s, not significant; * p < 0.05,
** p < 0.01. (D) Immunohistochemical staining of PrPSc in the hippocampus of Sort1-/- and Sort1+/+ female mice at 60
and 90 dpi and at terminal stage. PBS-inoculated mice brain hippocampus was also stained as a control. The brains
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Discussion
In the present study, we showed that PrPSc accumulation could be enhanced through PrPSc-
stimulated degradation of sortilin, a member of the VPS10P sorting receptor family. Sortilin
functions as a negative regulator for PrPSc accumulation by sorting PrPC and PrPSc to the late
endosome/lysosome protein degradation pathway. However, PrPSc stimulates sortilin to be
degraded in lysosomes, thereby disturbing the inhibitory role of sortilin and eventually leading
to the further accumulation of PrPSc.
PrPC is a GPI-anchored membrane protein located in raft domains and, to a lesser extent,
in non-raft domains. Some of the PrPC molecules internalized are delivered back to the cell
surface directly or indirectly via the recycling endosome compartments and others are trans-
ported to lysosomes for degradation [7] (Fig 9A). We showed that sortilin could directly inter-
act with PrPC on the cell surface through the VPS10P domain through the residues 610–753
encompassing cysteine rich 10CCs [23] of sortilin and the N-terminal residues 23–88 of PrPC.
Sortilin-knockdown increased PrPC on the cell surface and reduced the localization of PrPC to
lysosomes, suggesting that the increased surface expression of PrPC in sortilin-knockdown
cells might be caused by the decreased trafficking of PrPC to lysosomes for degradation. Sorti-
lin was predominantly located in non-raft domains, and PrPC accumulated at raft domains
and decreased in non-raft domains in sortilin-KO cells. It is thus conceivable that sortilin
could function to retain PrPC in non-raft domains and be involved in trafficking of non-raft
surface PrPC to lysosomes for degradation (Fig 9A). Low-density lipoprotein receptor-related
protein 1 has also been reported as a candidate cargo receptor for the non-raft PrPC [24]. A
sortilin-independent pathway may also play a role in PrPC internalization (Fig 9A). We
showed that sortilin deficiency increased PrPC at raft domains and shifted PrPC internalization
into the recycling endosomes from lysosomes in cells. It is thus conceivable that the internali-
zation of raft PrPC to the recycling endosomes could be sortilin-independent (Fig 9A). Taken
together, these results suggest that PrPC located in non-raft domains could be internalized to
lysosomes for degradation partly via the sortilin-dependent pathway while an internalization
pathway to direct PrPC from raft domains to the endocytic recycling pathway could be sorti-
lin-independent (Fig 9A).
Sortilin-knockdown increased PrPSc in prion-infected cells. In contrast, overexpression of
sortilin decreased PrPSc. Moreover, sortilin-KO mice developed the disease earlier than wild-
type mice after intracerebral inoculation with RML prions, with earlier accumulation of PrPSc
in their brains. These results indicate that sortilin is a negative regulator for PrPSc accumula-
tion. Raft domains may be a site for the conversion of PrPC into PrPSc [25], although the exact
site of PrPSc production remains controversial. Sortilin could retain surface PrPC at non-raft
domains and transport it to lysosomes for degradation, thereby reducing PrPC located in raft
domains. It is thus possible that the reduction of PrPC in raft domains by sortilin could delay
the conversion of PrPC into PrPSc, eventually leading to less accumulation of PrPSc. Sortilin
also interacts with PrPSc. Kinetics studies for PrPSc showed that knockout of sortilin delayed
PrPSc clearance in prion-infected cells. Thus, sortilin also could function to sort PrPSc for deg-
radation, reducing PrPSc accumulation. Some PrPSc molecules are trafficked to lysosomes for
degradation via the endolysosomal pathway from the cell surface [21,26,27]. Others are retro-
gradely transported to the Golgi apparatus where they are subjected to Golgi quality control
and trafficked to lysosomes for degradation [28]. Sortilin is expressed on the cell surface and
removed from PBS-inoculated Sort1-/- mice aged 16, 20, and 30 weeks were used as controls for 60 and 90 dpi and
terminal stage, respectively. Bar, 300 μm.
https://doi.org/10.1371/journal.ppat.1006470.g008
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Fig 9. A possible amplification model of PrPSc in prion infected cells. (A) Sortilin-dependent and
-independent endocytosis of PrPC in uninfected cells. A portion of PrPC is endocytosed with sortilin and
trafficked to lysosomes for degradation. Others are trafficked either to lysosomes for degradation or to the
recycling pathway in a sortilin-independent way. (B) Endocytosis of PrPC and PrPSc in prion-infected cells.
Prion infection stimulates lysosomal degradation of sortilin, thereby impairing the sortilin-mediated trafficking
of PrPC and PrPSc to lysosomes. As a result, PrPC and PrPSc are increased at the raft domains and
endocytosed via the sortilin-independent pathway, increasing the conversion of PrPC into PrPSc. The
decreased degradation of PrPSc and the increased conversion of PrPC into PrPSc both contribute to the
constitutive production of PrPSc in prion-infected cells. Dashed arrows indicate restricted trafficking. EE: early
endosomes, RE: recycling endosomes, LE: late endosomes, Lys: lysosomes, PM: plasma membrane.
https://doi.org/10.1371/journal.ppat.1006470.g009
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the Golgi apparatus [29]. Therefore, sortilin might be involved in both degradation trafficking
pathways of PrPSc. However, a large portion of sortilin and PrPSc molecules differed in their
membrane microdomain localization on the cell surface. Sortilin was predominantly detected
in non-raft domains. In contrast, PrPSc was exclusively located in raft domains. It is thus likely
that the sortilin-mediated lysosomal degradation of PrPSc from the cell surface through their
direct interaction might be, if any, a minor event. We previously reported that PrPSc was abun-
dantly detected in the recycling endosomes of prion-infected cells, suggesting that PrPSc mole-
cules accumulated in the recycling endosomes also might not be directly affected by sortilin.
Sortilin was reduced in both prion-infected cultured cells and mouse brains. Sortilin
mRNA was not decreased in prion-infected cells. Reduction of sortilin in prion-infected cells
was recovered by treatment with lysosomal inhibitors but not proteasomal inhibitor, suggest-
ing that prion infection could stimulate degradation of sortilin in lysosomes. Immunofluores-
cent staining of freshly infected cells revealed that sortilin was barely detectable in PrPSc-
positive cells but abundant in PrPSc-negative cells. PrPSc accumulation preceded the reduction
of sortilin. These results suggest that PrPSc accumulated after prion infection could cause sorti-
lin degradation in lysosomes in a cell-autonomous fashion, and that the enhanced degradation
of sortilin could abrogate the negative role of sortilin in PrPSc accumulation in prion-infected
cells. Thus, sortilin-mediated sorting of PrPC and PrPSc to lysosomes for degradation could be
disturbed in prion-infected cells, causing an increase in PrPC and PrPSc and eventually leading
to progressive accumulation of PrPSc (Fig 9B). In prion-infected cells, due to the disturbed
function of sortilin, PrPC might also be increasingly located in raft domains, where PrPC is
postulated to efficiently convert into PrPSc [25], and might be internalized into the recycling
endosomes, where PrPSc was reported to be abundantly detectable [26] (Fig 9B). Increased
localization of PrPC in raft domains and in the recycling endosomes in prion-infected cells
also could contribute to progressive accumulation of PrPSc by increasing the conversion of
PrPC into PrPSc. Elucidation of the mechanism by which PrPSc accumulation stimulates the
lysosomal degradation of sortilin would be helpful to further understanding of the mechanism
for the progressive accumulation of PrPSc.
Sortilin also regulates neuronal cell viability by controlling the release of pro- and matured-
form of neurotrophins (NTs), such as NGF and brain-derived neurotrophic factor, as does the
transport of their receptors, TrkA, TrkB, and TrkC, to the plasma membrane [9]. No gross
abnormalities were reported in Sort1-/- [11,22], probably due to compensatory mechanisms of
other family molecules. However, cultured dorsal root ganglion neurons lacking sortilin
showed impaired neurite outgrowth upon NGF stimulation [11]. Loss of sortilin also aggra-
vated neurological phenotypes observed in p75 NT receptor (p75NTR)-KO mice [11]. Sortilin
also acts as a co-receptor of p75NTR against proNTs to transduce cell death signals [30]. We
found that sortilin was significantly reduced in prion-infected cells and mouse brains, and that
the NGF signaling was disturbed in prion-infected cells. It might thus be interesting to investi-
gate whether or not the sortilin-mediated NT signals are involved in the pathogenesis of prion
disease.
It remains controversial whether or not degradation of sortilin might be stimulated in lyso-
somes in other neurodegenerative diseases. Reduced levels of sortilin have been reported in
the limbic and occipital regions of AD brains [31]. To the contrary, increased expression of
sortilin has been demonstrated in the temporal cortex of AD brains [32]. Other investigators
showed no alteration of sortilin levels in the superior frontal and superior temporal cortices of
AD brains [33].
In short, we presented a novel accumulation mechanism of PrPSc through degradation of
sortilin. Prion infection stimulated degradation of sortilin in lysosomes, reducing sortilin levels
in prion-infected cells. The reduction of sortilin disturbs its function to sort PrPC and PrPSc to
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the late endosomal/lysosomal compartments for degradation. As a result, PrPC is increasingly
converted to PrPSc and PrPSc degradation is delayed, and eventually PrPSc progressively accu-
mulates in prion-infected cells. Thus, accelerating the sortilin-mediated lysosomal degradation
of PrPC and PrPSc might be therapeutic in prion diseases.
Materials and methods
Ethics statement
All animal experiments complied with Japanese legislation (Act on Welfare and Management
of Animals, 1973, revised in 2012). The Ethics Committee of Animal Care and Experimenta-
tion of Tokushima University approved the animal experiments in this study (approval num-
ber T27-102). Animals were cared for in accordance with The Guiding Principle for Animal
Care and Experimentation of Tokushima University and guidelines under the jurisdiction of
the Ministry of Education, Culture, Sports, Science and Technology, Japan (Fundamental
Guidelines for Proper Conduct of Animal Experiment and Related Activities in Academic
Research Institutions, 2006).
Abs
The antibodies used in this study are as follows: rabbit anti-sortilin Abs (12369-1AP, Protein-
tech, Rosemont, IL), goat anti-sortilin Abs (AF2934, R&D systems, Minneapolis, MN), mouse
monoclonal anti-sortilin Ab (clone 48, BD Bioscience, San Jose, CA), sheep anti-SorLA Abs
(AF5699, R&D systems), goat anti-SorCS1 Abs (AF3457, R&D systems), sheep anti-SorCS2
Abs (AF4237, R&D systems), rat anti-SorCS3 Abs (MAB3067, R&D systems), rat anti-LAMP1
Ab (ab25245, Abcam, UK), rabbit anti-Rab9 Abs (EPR13272, Abcam), rabbit anti-Rab11 Abs
(5589, Cell signaling, MA, USA), rabbit anti-flotillin-2 Abs (3436, Cell signaling), mouse anti-
β-actin Ab (A5316, Sigma-Aldrich, St. Louis, MO), 6D11 mouse anti-PrP Ab (SIG-39810, Bio-
legend, San Diego, CA), SAF61 mouse anti-PrP Ab (A03205, Bertin pharma, Montigny le Bre-
tonneux, France), SAF83 mouse anti-PrP Ab (A03207, Bertin pharma), rabbit anti-PrP Abs
(18635, Immuno Biological Laboratories, Gunma, Japan), rabbit anti-TSG101 Ab (14497-
1-AP, ProteinTech, IL, USA), rabbit anti-flottilin-1 Ab (Ab 41927, Abcam), mouse anti-
GM130 Ab (610823, Transduction Laboratories, CA, USA), rabbit anti-Bcl-2 Ab (#3498, Cell
Signaling), mouse anti-EEA1 Ab (610456, Transduction Laboratories), mouse anti-Erk1 Ab
(610456, BD Biosciences), mouse anti-pErk1/2 Ab (612358, BD Biosciences), Alexa Fluoro
488-conjugated anti-mouse IgG Abs (Thermo Fisher Scientific, Rockford, IL), Alexa Fluoro
546-conjugated anti-goat IgG Abs (Thermo Fisher Scientific), Alexa Fluoro 546-conjugated
anti-rat IgG Abs (Thermo Fisher Scientific), Alexa Fluoro 488-conjugated anti-goat IgG Abs
(Thermo Fisher Scientific). Mouse anti-PrP Ab clone 132 was kindly gifted from Prof Horiu-
chi, Hokkaido University [21].
Plasmid construction and recombinant proteins
A mouse sortilin cDNA fragment was amplified from mouse brain QUICK-clone cDNA
(Clontech, California, USA) by using PCR (primers; 5’-cctctcgagatggagcggccccggggagct-3’,
5’-ctcaagcttctattccaggaggtcctcatctga-3’) and the amplified fragment was subcloned into
pcDNA3.1(-) (Invitrogen) to make an expression vector for full-length sortilin, designated as
pcDNA-Sortilin. DNA fragments encoding the VPS10P domain of sortilin, which corresponds
to residues 76–750, (primers; 5’-cctctcgagggcgcgcccgccgaggaccaa-3’, 5’-ctcaagcttctaggaattctg
ctttgtggg-3’) were also amplified by PCR using pcDNA-Sortilin as a template and subcloned
into pGEX4T-2 (GE healthcare, Little Chalfont, UK) to express glutathione S-transferase
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(GST)-tagged VPS10P domain of sortilin in E coli. GST-tagged VPS10P domain and GST were
induced in E. coli with 0.1 mM isopropyl thiogalactoside at 37˚C for 3 h and purified with glu-
tathione-beads. His-tagged recombinant full-length mouse PrP and PrP without residues 23–
88 were prepared as previously described [34].
For construction of an expression vector, termed pEF1-moPrP(3F4), encoding full-length
mouse PrP with a 3F4 tag, the BamH I/Xba I-digested fragment of pcDNA3.1-moPrP(3F4)
[35] was inserted into BamH I/Xba I-digested pEF1/Myc-His (Invitrogen). To construct an
expression vector, pEF1-moPrP(3F4)Δ23–88, encoding 3F4-tagged mouse PrP with residues
23–88 deleted and the 5’ fragment of moPrP(3F4)Δ23–88 cDNA was amplified by PCR
using pcDNA3.1-moPrP(3F4) as a template with a BamHI-PrP(ATG)-S sense primer (5’-
tcggatcccgtcatcatggcgaac-3’; underlined, BamH I site; bold, start codon) and a moPrP(3F4)
Δ23–88 anti-sense primer (5’-cctccttggccgcagaggccga-3’; underlined, residues 89–90; italic,
residues 19–22). Then, full-length moPrP(3F4)Δ23–88 cDNA was amplified by PCR using
pcDNA3.1-moPrP(3F4) as a template with the amplified 5’ fragment as a sense primer and a
PrP(stop)-XbaI-AS anti-sense primer (5’-cctctagagctcatcccacgatcag-3’; underlined, Xba I site;
bold, stop codon). After sequence confirmation, the amplified fragment was inserted into
BamH I/Xba I-digested pEF1/Myc-His (Invitrogen).
For the construction of a Sortilin-mycHis expression vector, cDNA encoding full-length
sortilin was amplified using pcDNA-Sortilin as a template by PCR with a primer pair of Sort-
1 (5’-cctctcgagatggagcggccccgggagct-3’; underlined, Xho I site; bold, start codon) and Sort-
12 (5’-ctcaagcttttccaggaggtcctcatctga-3’; underlined, Hind III site) and inserted into Xho I/
Hind III digested pcDNA3.1/mycHis(-)A (Invitrogen). Deletion mutants of sortilin were
constructed as follows. For construction of sortilinΔ76–177, two DNA fragments with an
overlapping DNA segment were amplified using pcDNA-Sortilin as a template by PCR with
a primer pair of Sort-1 and Sort-D4 (5’-tatcacctttccgcggcgccaacggccagc-3’; italic, residues 70–
75; underlined, residues 178–183) and a primer pair of Sort-D3 (5’-cgttggcgccgcggaaaggtga
tactaaca-3’; underlined, residues 72–75; italic, residues 178–183) and Sort-12. These two
fragments were hybridized at the overlapping DNA segment and subjected to PCR with a
primer pair of Sort-1 and Sort-12, resulting in amplification of a DNA fragment encoding
sortilinΔ76–177. The amplified fragment was inserted into Xho I/Hind III digested
pcDNA3.1/mycHis(-)A (Invitrogen). Other DNA fragments encoding other sortilin mutants
were similarly amplified and inserted into Xho I/Hind III digested pcDNA3.1/mycHis(-)A
(Invitrogen). Sort-1 and Sort-D6 (5’-gaaggtttttccagagttctcaggaccaat-3’; italic, residues 172–
177; underlined, residues 291–294) and Sort-D5 (5’-cctgagaactctggaaaaaccttcaaaacc-3’;
underlined, residues 174–177; italic, residues 291–296) and Sort-12 were used for construc-
tion of sortilinΔ178–290. Sort-1 and Sort-D8 (5’-tatatagacccccaagtcggatgttctcca-3’; italic, resi-
dues 285–290; underlined, residues 410–413) and Sort-12 and Sort-D7 (5’-acatccgacttggg
ggtctatataacaagc-3’; underlined, residues 287–290; italic, residues 410–415) were used for
construction of sortilinΔ291–409. Sort-1 and Sort-D10 (5’-ggagtaacccccacggagggaagtcacgtt-
3’; italic, residues 404–409; underlined, residues 509–612) and Sort-D9 (5’-acttccctccgtggg
ggttactcctgggcg-3’; underlined, residues 406–409; italic, residues 509–514) and Sort-12 were
used for construction of sortilinΔ410–508. Sort-1 and Sort-D12 (5’-atcctcttcacaatcatctgagat
gtacac-3’; italic, residues 503–508; underlined, residues 610–613) and Sort-D11 (5’-atctcagat
gattgtgaagaggatgactat-3’; underlined, residues 505–508; italic, residues 610–615) and Sort-12
were used for construction of sortilinΔ509–609. Sort-1 and Sort-D14 (5’-aatagggacagaattc
cgctcaaggatgtc-3’; italic, residues 604–609; underlined, residues 754–757) and Sort-D13 (5’-
cttgagcggaattctgtccctattatcctg-3’; underlined, residues 606–609; italic, residues 754–759) and
Sort-12 were used for construction of sortilinΔ610–753.
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Cell lines and animals
Cells were maintained at 37˚C with 5% CO2 in air in Dulbecco’s Modified Eagle Medium
(DMEM, Invitrogen, Carlsbad, CA) containing 10% fetal bovine serum (FBS). N2aC24,
N2aC24L1-3, and cured N2aC24L1-3 cells were previously established elsewhere [26]. N2aC24
cells were cloned from mouse neuroblastoma N2a cells overexpressing exogenous mouse
PrPC. N2aC24L1-3 cells were cloned from N2aC24 cells persistently infected with 22L scrapie
prions. Cured N2aC24L1-3 cells are cured from prion infection by treatment with SAF32 anti-
PrP Ab and then maintained in antibody-free DMEM with 10% FBS. ScN2a cells (kindly gifted
from Prof Doh-ura, Tohoku University) were N2a cells persistently infected with RML scrapie
prions.
Sortilin-KO cells, ΔSort#1 and #2 cells, were established using the CRISPR-Cas genome
editing system. N2aC24 cells were transduced with pRGEN-Cas9-CMV (Takara bio, Shiga,
Japan) and pRGEN_Mouse-Sort1_U6_SG_1 targeting the sequence (5’-cctgccgccgtcggccag-
gaccg-3’) (Takara bio), and subjected to limiting dilution cloning. Knockout of sortilin in
ΔSort#1 and #2 cells was confirmed by Western blotting.
PrP-KO N2a cells, termed N2aΔPrP cells, were also established using the CRISPR-Cas
genome editing system. N2a cells were transduced with pRGEN-Cas9-CMV (Takara bio)
and pRGEN_PrP_U6_SG_1 targeting the sequence (5’-accggtggaagccggtatcccgg-3’) (Takara
bio), and subjected to limiting dilution cloning. Knockout of PrPC in N2aΔPrP cells was con-
firmed by Western blotting. To clone N2aΔPrP cells expressing full-length wild-type PrPC or
PrPΔ23–88, pEF1-moPrP(3F4) and pEF1-moPrP(3F4)Δ23–88 were linearized by Sca I and
transfected into N2aΔPrP cells. The cells were treated with G418 and the G418-resistant cells
were cloned by limiting dilution, resulting in establishment WT#1 and #2 cells and Δ23–88#1
and #2 cells.
Sortilin-KO (Sort1-/-) mice used in this study were previously produced elsewhere [11,22].
Sort1-/- mice having been backcrossed for 10 generations into C57BL/6 were intercrossed with
C57BL/6 mice (Charles River Laboratories, Kanagawa, Japan), and the resulting heterozygous
mice (Sort-/+) were then intercrossed to obtain Sort-/- and wild-type (Sort+/+) mice.
Immunoprecipitation
Cells were lysed in buffer A [20 mM MES-KOH (pH 7.0), 0.15 M KCl, 1 mM DTT, 10% glyc-
erol, 0.2% (w/v) CHAPS] containing protease inhibitor cocktail (Nakalai tesque, Kyoto,
Japan). The lysate was cleared by centrifugation for 5 min at 20,000×g at 4˚C and the superna-
tant was transferred to a new tube. 500 μL of supernatant containing 500 μg of total proteins
were incubated with 1 μg of indicated Abs for 2 h. 5 μL of protein-G sepharose (GE healthcare)
was added and the mixture was rotated for 4 h at 4˚C. Thereafter, protein-G sepharose was
precipitated and the precipitant was washed with buffer A 5 times. The final precipitate with
protein-G sepharose was suspended in 50 μL of Laemmli’s sample buffer, heated, and sub-
jected to Western blotting to detect proteins of interest with appropriate Abs.
Protein interaction assay using Dynabeads protein-G
For detection of interaction of PrPSc and sortilin, 15 μL of Dynabeads protein-G (Thermo
Fisher Scientific) was added instead of protein-G sepharose. Immunocomplexes were collected
using magnet instead of centrifugation and washed with buffer A. The same procedure was
repeated 5 times. The finally collected complexes were suspended in 45 μL of buffer B [150
mM NaCl, 50 mM Tris-HCl (pH 7.5), 0.5% (w/v) Triton X-100, 0.5% (w/v) sodium deoxycho-
late, 1 mM EDTA] containing 100 μg/ml proteinase K (PK) and incubated at 37˚C for 60 min
with mixing at 1,100 rpm using Thermomixer (Eppendorf, Hamburg, Germany). The PK-
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treated samples were denatured in Laemmli’s sample buffer and subjected to Western blotting
to detect PrPSc.
For detection of interaction of PrPC and sortilin on the cell surface, cells were washed with
ice-cold PBS. After blocking of the cells with buffer C [20 mM MES-KOH (pH 7.0), 0.15 M
KCl, 0.25 M sucrose] containing 0.5% (w/v) bovine serum albumin (BSA) for 10 min at 4˚C,
the cell surface PrP was labeled with 1 μg/mL of SAF61 anti-PrP Ab in buffer C containing
0.5% (w/v) BSA for 30 min at 4˚C. After washing the cells with ice-cold-PBS, they were sus-
pended in 1 mL of buffer C. To homogenize the cells, the cell suspension was passed through a
27G needle 10 times. The homogenate was centrifuged at 500×g for 10 min at 4˚C and the
supernatant was incubated with 15 μL of Dynabeads protein-G with gentle agitation for 2 h at
4˚C. The beads were collected by magnet and washed with buffer C. The collected immuno-
complexes on the beads were washed with buffer A 5 times and finally suspended in 50 μL of
Laemmli’s sample buffer and subjected to Western blotting.
GST pulldown assay
2 μg of GST-tagged VPS10P domain of sortilin, which was pre-bound to 5 μL of glutathione
beads, was incubated with 2 μg of His-tagged full-length recombinant PrP or His-tagged
recombinant PrP lacking residues 23–88 in buffer A containing protease inhibitor cocktail for
2 h with rotation at 4˚C. The precipitate was washed with buffer A 5 times, suspended in
Laemmli’s sample buffer, heated, and subjected to Western blotting. GST-tagged VPS10P
domain and His-tagged PrPs were detected with rabbit polyclonal anti-sortilin Abs and
RGS-His Ab, respectively.
Biotinylation of cell surface proteins
Biotinylation of cell surface proteins was carried out as described elsewhere [26]. In brief, cells
(85–95% confluent) were washed with PBS and incubated with Sulfo-NHS-LC Biotin (Thermo
Fisher Scientific) in PBS for 30 min at room temperature. The cells were then washed with 0.1
M glycine in PBS and lysed in buffer B. The lysate was mixed with NeutrAvidin UltraLink
Resin (Thermo Fisher Scientific) for 4 h at 4˚C and the biotinylated protein-resin complexes
were collected by brief microcentrifugation. The complexes were then washed with the buffer
and heated at 99˚C for 10 min in Laemmli’s sample buffer to separate the biotinylated proteins
from the complexes. The biotinylated proteins in the supernatant were subjected to Western
blotting.
Immunofluorescence staining
Cells were stained with indicated Abs as described previously [26]. In brief, cells grown on cov-
erslips were fixed in 3% paraformaldehyde (PF) for 15min and treated with 0.1 M glycine in
PBS for 10 min. Permeabilization was carried out using 0.1% Triton X-100 in PBS for 4 min at
RT. To detect PrPSc, the cells were treated with 5 M guanidinium thiocyanate for 10 min at
RT. After washing with PBS, the cells were incubated with the first Ab in 5% FBS in PBS and
then with fluorescent secondary Ab. For detection of PrPSc, mouse anti-PrP Ab clone 132 [21]
(kindly gifted from Prof Horiuchi, Hokkaido University) was used as a first Ab. After washing,
the coverslips were mounted with Prolong Gold antifade reagent (Invitrogen). Fluorescence
images were obtained using BIOREVO BZ-9000 (Keyence, Osaka, Japan), which is equipped
with haze reduction function, which enables production of fluorescent images very similar to
those taken by a confocal microscope. To assess the co-localization of proteins of interest,
Pearson’s correlation coefficient was calculated using Co-localization Plugin (JaCoP) tool in
Image J [36].
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Internalization assay of antibody-labeled surface PrP
Cells were washed with ice-cold PBS and treated with 1% BSA in PBS for 10 min at 4˚C prior
to incubation with the indicated anti-PrP Abs (1 μg/mL) for 10 min at 4˚C in 1% BSA-contain-
ing PBS. The cells were then washed with ice-cold PBS and incubated at 37˚C for 2 h. Thereaf-
ter, the cells were fixed with 3% paraformaldehyde, permeabilized with 0.1% Triton X-100,
and stained with Alexa Fluoro 488 anti-mouse IgG Ab (Thermo Fisher Scientific). Fluorescent
signals were observed using BIOREVO BZ-9000 (Keyence) and their intensities were analyzed
using BZ-II analyzer (Keyence).
Internalization assay of biotinylated surface PrP
Cells were washed three times with ice-cold PBS (pH7.4) and incubated with 5 mg/mL sulfo-
NHS-SS-biotin (Thermo Fisher Scientific) in PBS (pH 7.4) at 4˚C for 10 min to biotinylate cell
surface proteins. After washing the cells twice with ice-cold PBS (pH 7.4) and incubation with
50 mM glycine in PBS (pH 7.4), the cells were further washed twice with ice-cold PBS (pH
7.4). Thereafter, the cells were incubated in DMEM medium at 37˚C. After 2 h-incubation, the
cells were washed three times with ice-cold PBS (pH 7.4), and biotin was removed from the
proteins still on the cell surface by incubating the cells with 100 mM reducing glutathione in
PBS (pH 7.4) at 37˚C for 10 min. After washing the cells with ice-cold PBS (pH 7.4), the cells
were lysed in buffer B containing protease inhibitor cocktail (Nakalai tesque). The lysate was
cleared by centrifugation for 5 min at 20,000×g at 4˚C and the supernatant was transferred to a
new tube. 20 mL of NeutrAvidin beads (Thermo Fisher Scientific) was added into the cell
lysate containing 300 mg of proteins and the mixture was rotating at 4˚C for 2 h. After washing
the beads with lysis buffer, the beads was suspended in 50 mL of SDS-PAGE sample buffer and
subjected to Western blotting with 6D11 anti-PrP Ab.
Transfection
Cells were transiently transfected with pcDNA-Sortilin and pcDNA-SortilinΔC at the final
concentration of 1.6 μg/ml using lipofectamin 2000 (Invitrogen). The expression of sortilin
and PrPC was knocked down using Stealth RNAi siRNAs (Invitrogen): Sortilin siRNA #1, 5’-
ccaagucaaauucugucccuauuau-3’; Sortilin siRNA #2, 5’-gagaacucuggaaaggugauacuaa-3’; PrP
siRNA #1, 5’-gggacaaccucauggugguaguugg-3’; PrP siRNA #2, 5’-ccaguggaucaguacagcaaccaga-
3’. Stealth RNAi Negative Control Duplex was purchased from Invitrogen. Each siRNA
was transfected into cells at the final concentration of 10 nM using lipofectamin RNAiMax
(Invitrogen).
RT-PCR
Total RNA was extracted using an RNeasy Mini Kit (QIAGEN, Hilden, Germany) and first-
strand cDNA was synthesized using SuperScript III First-Strand Synthesis System for RT-PCR
(Invitrogen). The synthesized cDNAs were amplified with the following primer sets: 5’-aagcag
gactcccgcccacag-3’ and 5’-ttccaggaggtcctcatctga-3’ for sortilin cDNA, 5’-tacagcaaccagaacaac-3’
and 5’-tcatcccacgatcaggaagat-3’ for PrP cDNA, and 5’-cctgccaagtatgatgacatc-3’ and 5’-gctgtag
ccgtattcattgtc-3’ for glyceraldehyde-3-phosphate dehydrogenase cDNA.
Fractionation of membrane microdomains
Cells grown to ~80% confluency in a 35 mm tissue culture dish were suspended in 250 μL of
MBS buffer [25 mM MES-NaOH (pH 6.5), 0.15 M NaCl] containing 1% (w/v) Triton X-100,
and homogenized by being passed through a 21G-needle 15 times. After centrifugation at
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500×g for 5 min at 4˚C, 220 μL of the supernatant was transferred to a new tube and mixed
with 220 μL of MBS buffer containing 80% (w/v) sucrose to make 40% (w/v) sucrose. 200 μL
of the sample was placed at the bottom of a discontinuous sucrose gradient consisting of
600 μL of 30% (w/v) sucrose and 200 μL of 5% (w/v) sucrose. The sample was centrifuged at
140,000×g for 24 h at 4˚C in an S55S rotor (Hitachi Koki, Tokyo, Japan). Ten fractions
(100 μL/fraction) were collected from the top.
Prion infection
Brains were removed from terminally ill wild-type C57BL/6 mice infected with RML prions. A
single brain was homogenized (10%, w/v) in PBS using a multi-beads shocker (Yasui Kikai,
Osaka, Japan) and then diluted to 1% with PBS. Two 1% (w/v) brain homogenates were mixed
to prepare the homogenate of 2 pooled brains and the resulting homogenate was intracere-
brally inoculated into a 4–5 week-old mouse with its 20 μL aliquot. The signs for disease-
related symptoms were evaluated as previously described [37].
For infection of cells, cells were seeded at a density of 2×105 cells/well in a 6-well tissue cul-
ture plate. At 4 h after cell seeding, the clarified RML-infected brain homogenate [34] contain-
ing 50 μg proteins was added to the well and cells were subsequently passaged every 3 days.
Immunohistochemistry
Paraffin-embedded samples were sectioned, deparaffinized, and rehydrated. The samples were
autoclaved in 1 mM HCl at 121˚C for 5 min and subsequently washed with PBS. The samples
were then digested with 50 μg/mL PK in PBS at 37˚C for 30 min, treated with 3 M guanidine
thiocyanate for 10 min, and washed with PBS. After blocking with 5% FBS in PBS for 1 h, the
sampled were incubated with 6D11 anti-PrP Ab for 2 h, washed with PBS, and treated with
ImmPRESS REAGENT Anti-Mouse IgG (Vector Laboratories, U.S.A) for 30 min. After wash-
ing with PBS, the samples were incubated with ImmPACT DAB (Vector Laboratories) for 180
sec for staining.
Western blotting
Western blotting was performed as reported previously [26]. To evaluate protein expression,
signals were densitometrically measured using LAS-4000 mini (Fujifilm Co., Tokyo, Japan).
The measured intensity of target proteins was normalized against the signal intensity of β-
actin used as an internal control protein.
NGF stimulation
Cells were removed from a tissue culture dish by pipetting and transferred to a new tube. After
washing with DMEM medium, cells were collected by centrifugation at 500×g for 2 min at
4˚C, suspended in 1 mL of DMEM medium containing 2 nM NGF (Thermo Fisher Scientific),
transferred into a well of 12 well plate, and incubated for 10 min at 37˚C in a 5% CO2 incuba-
tor. The cells were collected by centrifugation at 500×g for 5 min at 4˚C and washed with ice-
cold PBS. The pellet was lysed in 200 μL of buffer B containing protease inhibitor cocktail
(Nakalai tesque). The lysate was cleared by centrifugation at 12,000×g for 2 min at 4˚C and the
supernatant was subjected to Western blotting.
Isolation of exosomes
Cells were cultured in 2 mL of DMEM medium containing 10% exosome-depleted FBS (Sys-
tem Bioscience, CA,USA) in a 6 well tissue culture plate for 72 h and the culture medium was
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collected. The culture medium was centrifuged at 2,000×g for 10 min at 4˚C. The supernatant
was passed through 0.22 μm pore filter membrane and the flow-through was centrifuged at
10,000×g for 30 min at 4˚C. Exosomes in the supernatant were collected by ultracentrifugation
at 100,000×g for 1 h at 4˚C and washed with PBS. The exosomes were dissolved in 100 μL of
Laemmli’s sample buffer and subjected to Western blotting.
Detection of the C1 fragment
Cell lysate containing 20 μg proteins was incubated in 20 μL of (1×) glycoprotein denaturing
buffer (0.5% SDS, 40mM DTT) at 99˚C for 10 min. Thereafter, 3μl of 10% NP-40, 3 μL of
(10×) Glycobuffer, 3.5 μl of distilled water and 0.5 μL of PNGase (500 units/μl) (New England
BioLabs, MA, USA) were added. After 60 min incubation at 37˚C, samples were mixed with
10 μL of (4×) Laemmli’s sample buffer and subjected to Western blotting.
Statistical analysis
Survival and incubation times are analyzed using the log-rank test. Other data were analyzed
using the one-way ANOVA.
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S1 Fig. PrPC interacts with sortilin but not with other VPS10P receptors. Co-immunopre-
cipitation assay was carried out in N2aC24 cells with SAF61 anti-PrP Ab. The resulting immu-
noprecipitates were subjected to Western blotting with Abs against each protein. Arrows and
arrowheads indicate non-specific signals of the degraded fragment of protein G or the light
chain of Abs used in co-immunoprecipitation.
(TIF)
S2 Fig. Sortilin interacts with PrPC through residues 610–753. (A) Schematic diagrams of
full-length (full) sortilin and various deletion mutants of sortilin, all of which are tagged with a
mycHis motif. Sortilin is a single-pass transmembrane molecule consisting of a signal peptide
(red), a propeptide (yellow), a VPS10P domain (green), and a transmembrane region (blue).
Arabic numbers represent the codon numbers. (B) Immunoprecipitation assay of sortilin-KO
ΔSort#1 cells expressing full-length (full) sortilin and various deletion mutants of sortilin and
of PrP-KO ΔPrP#1 cell expressing full-length (full) sortilin using SAF61 anti-PrP Ab. Immu-
noprecipitates (IP) and the cell lysates (Lysate) were subjected to Western blotting for sortilin
with anti-myc Ab and for PrPC with 6D11 anti-PrP Ab. An arrow indicates light chains of the
Ab used in this assay.
(TIF)
S3 Fig. Interaction of PrPC and sortilin. Orthogonal views of double immunofluorescence
staining of PrPC (green) and sortilin (red) in non-permeabilized or permeabilized N2aC24
cells, with SAF83 anti-PrP Ab and goat polyclonal anti-sortilin Abs.
(TIF)
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S4 Fig. PrPC interacts with sortilin on the cell surface. (A) A simple description of the proto-
col used for detection of interaction of PrPC with sortilin on the cell surface. (B) Western blot-
ting for PrPC and sortilin in the immunocomplexes of SAF61 anti-PrP Ab from N2aC24 and
ΔPrP#1 cells. (C) Western blotting for sortilin expressing in N2aC24 and ΔPrP#1 cells.
(TIF)
S5 Fig. PrPC is increased in the brains of Sort1-/- mice. (A) Western blotting of the brains of
WT (Sort1+/+) and Sort1-/- mice for PrPC with 6D11 anti-PrP Ab. Sortilin was detected in
Sort1+/+ brains but not in Sort1-/- brains. (B) Quantification of PrPC densities after normaliza-
tion against β-actin intensities in (A). Data are means ± SD of 3 brains.  p< 0.001.
(TIF)
S6 Fig. Shading of PrPC and excretion of PrPC in exosomes are increased in sortilin-defi-
cient cells. (A) Western blotting for deglycosylated PrPC in N2aC24 cells transfected with con-
trol and sortilin siRNAs. Full-length deglycosylated PrPC and the C1 fragment were detectable.
Quantification of densities for full-length deglycosylated PrPC and the C1 fragment in (A).
Data are means ± SD of 3 independent samples.  p< 0.01. (B) Western blotting of the cell
lysates and exosomes from N2aC24 cells and sortilin-KO ΔSort#1 and #2 cells for PrPC with
6D11 anti-PrP Ab. TSG101 and flotillin-1, but not GM130 and Bcl-2, were detectable in exo-
somes. (C) Quantification of PrPC densities in (B). Data are means ± SD of 3 independent
samples.  p< 0.01,  p< 0.001.
(TIF)
S7 Fig. Localization of PrPC in late endosomes, recycling endosomes, and early endosomes.
Double immunofluorescence staining of PrPC (green) with the late endosome marker Rab9
(red) (A), the recycling endosome marker Rab11 (red) (C), and the early endosome marker
EAA1 (red) (E). Pearson’s correlation coefficient for co-localization of PrPC and Rab9 (B),
Rab11 (D) or EAA1 (F). Data are means ± SD of 6 cells.  p< 0.01,  p< 0.001.
(TIF)
S8 Fig. Impaired trafficking of PrPΔ23–88 to lysosomes. (A) Western blotting of full-length
wild-type PrPC and PrPΔ23–88 in WT cells and Δ23–88 cells after 12 h-treatment with or with-
out 20 mM NH4Cl. (B) Quantification of wild-type PrP
C and PrPΔ23–88 in (A) after normali-
zation against β-actin. Signal intensities in each lane were evaluated against that in NH4Cl-
untreated WT#1 cells. Data are means ± SD of 4 independent experiments.  p< 0.05,  p<
0.001. (C) Double immunofluorescence staining for PrPC and PrPΔ23–88 with the lysosome
marker LAMP1 in WT and Δ23–88 cells after 12 h-treatment with or without 20 mM NH4Cl.
(D) Pearson’s correlation coefficients for co-localization of PrPC or PrPΔ23–88 and LAMP1 in
WT#1 cells untreated (n = 149) or treated (n = 120) with NH4Cl, WT#2 cells treated (n = 121)
or untreated (n = 130) with NH4Cl, Δ23–88#1 cells treated (n = 124) or untreated (n = 138)
with NH4Cl, and Δ23–88#1 cells treated (n = 122) or untreated (n = 121) with NH4Cl. Data
are means ± SD.  p< 0.001. (E) Western blotting for sortilin in WT and Δ23–88 cells. (F)
Quantification of sortilin in (E) after normalization against β-actin. Signal intensities in each
lane were evaluated against that in WT#1 cells. Data are means ± SD of 4 independent experi-
ments. (G) Co-immunoprecipitation assay for PrPC or PrPΔ23–88 and sortilin using SAF61
anti-PrP Ab. Arrows and arrowheads indicate non-specific signals of the degraded fragment of
protein G or the light chain of Abs used in co-immunoprecipitation.
(TIF)
S9 Fig. Membrane microdomain distribution of PrPΔ23–88 in cells and PrPC in the brains
of Sort1-/- mice. (A) PrP-KO N2aΔPrP cells expressing WT PrPC, designated WT#1 and #2
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cells, and those expressing PrPΔ23–88, Δ23–88#1 and #2 cells, were subjected to discontinuous
sucrose gradient centrifugation. Each fraction was analyzed by Western blotting with 6D11
anti-PrP Ab. (B) Quantification of PrPC or PrPΔ23–88 in each fraction against the total PrPC
or PrPΔ23–88 in (A). The signal density in each lane was evaluated against the total signal
density of all lanes. Data are means ± SD of 3 independent experiments. (C) Discontinuous
sucrose gradient centrifugation of the brains from Sort1-/- and WT mice. Each fraction was
analyzed by Western blotting with 6D11 anti-PrP antibody. (D) Quantification of PrPC in
each fraction against the total PrPC in (C). The signal density in each lane was evaluated
against the total signal density of all lanes. Data are means ± SD of 3 brains.
(TIF)
S10 Fig. Membrane microdomain distribution of PrP molecules in prion-infected cells. (A)
Discontinuous sucrose gradient centrifugation of prion-infected N2aC24L1-3 cells. Each frac-
tion was treated with or without PK and analyzed by Western blotting with 6D11 anti-PrP Ab.
(B) Quantification of PrP in each fraction against the total PrP in (A). The signal density in
each lane was evaluated against the total signal density of all lanes. Data are means ± SD of 3
independent experiments.
(TIF)
S11 Fig. PrPSc degradation is delayed in sortilin-KO cells infected with prions. (A) PrPSc in
RML-infected N2aC24 (N2aC24/RML) and ΔSort#1 (ΔSort/RML) cells 36, 48, and 60 h after
transfection with control siRNA alone. (B) Quantification of PrPSc in (A) after normalization
against β-actin. Signal density in cells at 48 and 60 h was compared with that at 36 h. Data
are means ± SD of 3 independent experiments. n.s., not significant. (C) PrPSc in 22L prion-
infected N2aC24 (N2aC24/22L) and ΔSort#1 (ΔSort/22L) cells 36, 48, and 60 h after transfec-
tion with control siRNA or PrP-specific siRNAs (#1 and 2). (D) Quantification of PrPSc in (C)
after normalization against β-actin. Each signal intensity in PrP-knockdown cells was evalu-
ated against that in control siRNA-transfected cells in each blot. Data are means ± SD of 3
independent experiments.
(TIF)
S12 Fig. Sortilin expression is decreased in prion-infected cells. (A) Western blotting of
VPS10P receptors in infected N2aC24L1-3 cells and uninfected N2aC24. (B) Quantification of
the VPS10P receptors in (A) after normalization against β-actin. The signal density in infected
cells was evaluated against that in uninfected cells. Data are means ± SD of 3 independent
experiments. n.s., not significant. (C) RT-PCR for sortilin, PrP, and GAPDH in infected
N2aC24L1-3 and uninfected N2aC24 cells. (D) Western blotting of sortilin in N2a and ScN2a
cells. (E) Quantification of sortilin in (D) after normalization against β-actin. The signal den-
sity in ScN2a was evaluated against that in N2a cells. Data are means ± SD of 4 independent
experiments.  p< 0.001.
(TIF)
S13 Fig. Lysosomal degradation of sortilin is enhanced in prion-infected cells. (A) Western
blotting of sortilin in N2aC24 and N2aC24L1-3 cells 12 h after treatment with 20 mM NH4Cl
and 10 μM MG132. (B) Quantification of sortilin in (A) after normalization against β-actin.
The signal intensity of sortilin in NH4Cl- or MG132-treated cells was evaluated against that
in untreated cells. Data are means ± SD of 3 independent experiments. n.s, not significant;
 p< 0.01,  p< 0.001. (C) Western blotting for sortilin in N2aC24L1-3 cells 12 h after
treatment with 20 mM NH4Cl or 10 nM Concanamycin A. (D) Quantification of sortilin in
(C) after normalization against β-actin. The signal intensity of sortilin in NH4Cl- or Concana-
mycin A-treated cells was evaluated against that in untreated cells. Data are means ± SD of 3
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independent experiments. n.s, not significant;  p< 0.001.
(TIF)
S14 Fig. Impaired activation of ERK1/2 in prion-infected cells. (A) Western blotting of
uninfected N2aC24 and prion-infected N2aC24L1-3 cells for phosphorylated ERK1/2 and
total ERK1 after treatment with or without NGF. (B) Quantification of phosphorylated ERK1/
2 densities after normalization against β-actin densities in (A). Data are means ± SD of 3 inde-
pendent experiments.  p< 0.001. (C) Quantification of total ERK1 intensities in (A) after
normalization against β-actin intensities. Data are means ± SD of 3 independent experiments.
(TIF)
S15 Fig. Sortilin-KO male mice have accelerated prion disease with earlier accumulation of
PrPSc in their brains. (A) Kaplan-Meier survival curves for Sort1-/- (n = 21) and Sort1+/+
(n = 23) male mice inoculated with RML prions.  p< 0.001. (B) Western blotting of PrPSc
in the brains of Sort1-/- and Sort1+/+ mice at 45, 60, and 90 dpi and at terminal stage. (C) Quan-
tification of PrPSc in (B) after normalization against β-actin. Signal intensity in Sort1-/- mice
was evaluated against that in Sort1+/+ mice. Data are means ± SD of 4–6 independent brains.
n.s., not significant;  p< 0.05. (D) Immunohistochemical staining of PrPSc in the brain hippo-
campus areas of Sort1-/- and Sort1+/+ mice at 60 and 90 dpi and at terminal stage. Bar, 300 μm.
(TIF)
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